Log in to save to my catalogue

Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials

Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a377348373f54d3fa5d9d751ff9c4bd7

Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials

About this item

Full title

Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials

Publisher

London: BioMed Central Ltd

Journal title

BMC family practice, 2021-10, Vol.22 (1), p.1-208, Article 208

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Polypharmacy is defined as the prescription of at least 5 different medicines for therapeutic or prophylactic effect and is a serious issue among elderly patients, who are frequently affected by multi-morbidity. Deprescribing is one of the proposed approaches to reduce the number of administered drugs, by eliminating those that are inapp...

Alternative Titles

Full title

Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a377348373f54d3fa5d9d751ff9c4bd7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a377348373f54d3fa5d9d751ff9c4bd7

Other Identifiers

ISSN

1471-2296

E-ISSN

1471-2296

DOI

10.1186/s12875-021-01557-y

How to access this item